Vertex Pharmaceuticals Incorporated

06/18/2021 | Press release | Distributed by Public on 06/18/2021 13:39

Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older Who Have at Least One F508del Mutation